Mairs and Power's NVS Position Overview
Mairs and Power (via Mairs & Power INC) currently holds 1,485 shares of Novartis AG (NVS) worth $204,737, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 45 quarters.
Based on 13F filings since 2013, Mairs and Power has maintained a long-term strategic position in NVS, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2016, adding 2,873 shares. Largest reduction occurred in Q3 2021, reducing 2,530 shares.
Analysis based on 13F filings available since 2013 Q2
Mairs and Power's Novartis (NVS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Novartis (NVS) Trades by Mairs and Power
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +1,485 | New Buy | 1,485 | $137.87 |
| Q3 2025 | -1,795 | Sold Out | 0 | $0.00 |
| Q2 2025 | +1,795 | New Buy | 1,795 | $121.01 |
| Q1 2024 | -2,024 | Sold Out | 0 | $0.00 |
| Q4 2023 | +2,024 | New Buy | 2,024 | $100.97 |
| Q2 2023 | -2,280 | Sold Out | 0 | $0.00 |
| Q4 2022 | +2,280 | New Buy | 2,280 | $90.72 |
| Q2 2022 | -2,309 | Sold Out | 0 | $0.00 |
| Q1 2022 | -227 | Reduce 8.95% | 2,309 | $87.92 |
| Q4 2021 | +2,536 | New Buy | 2,536 | $87.54 |
| Q3 2021 | -2,530 | Sold Out | 0 | $0.00 |
| Q1 2021 | -170 | Reduce 6.30% | 2,530 | $85.38 |
| Q4 2020 | -130 | Reduce 4.59% | 2,700 | $94.44 |
| Q3 2020 | -200 | Reduce 6.60% | 2,830 | $86.93 |
| Q1 2020 | +130 | Add 4.48% | 3,030 | $82.51 |
| Q2 2019 | -336 | Reduce 10.38% | 2,900 | $91.38 |
| Q4 2018 | -335 | Reduce 9.38% | 3,236 | $76.95 |
| Q2 2018 | -56 | Reduce 1.54% | 3,571 | $67.77 |
| Q1 2018 | -558 | Reduce 13.33% | 3,627 | $72.51 |
| Q3 2017 | -558 | Reduce 11.76% | 4,185 | $76.94 |
| Q2 2017 | -1,835 | Reduce 27.90% | 4,743 | $74.85 |
| Q1 2017 | -177 | Reduce 2.62% | 6,578 | $66.59 |
| Q4 2016 | -336 | Reduce 4.74% | 6,755 | $65.28 |
| Q3 2016 | +2,873 | Add 68.11% | 7,091 | $70.79 |
| Q1 2016 | -335 | Reduce 7.36% | 4,218 | $64.96 |
| Q1 2015 | -223 | Reduce 4.67% | 4,553 | $88.29 |
| Q4 2014 | -57 | Reduce 1.18% | 4,776 | $83.12 |
| Q3 2014 | +252 | Add 5.50% | 4,833 | $84.42 |
| Q1 2014 | +614 | Add 15.48% | 4,581 | $76.18 |
| Q4 2013 | -301 | Reduce 7.05% | 3,967 | $72.09 |
| Q3 2013 | -523 | Reduce 10.92% | 4,268 | $68.65 |
| Q2 2013 | +4,791 | Add 0.00% | 4,791 | $63.45 |
Mairs and Power's Novartis Investment FAQs
Mairs and Power first purchased Novartis AG (NVS) in Q2 2013, acquiring 4,791 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mairs and Power has held Novartis AG (NVS) for 45 quarters since Q2 2013.
Mairs and Power's largest addition to Novartis AG (NVS) was in Q2 2013, adding 4,791 shares worth $304,000.
According to the latest 13F filing for Q4 2025, Mairs and Power's firm, Mairs & Power INC, owns 1,485 shares of Novartis AG (NVS), valued at approximately $204,737.
As of the Q4 2025 filing, Novartis AG (NVS) represents approximately 0.00% of Mairs and Power's publicly disclosed stock portfolio, making it one of their key holdings.
Mairs and Power's peak holding in Novartis AG (NVS) was 7,091 shares, as reported at the end of Q3 2016.